Digital Intervention for Suicide Prevention

N/A

Waitlist Available

Research Sponsored by Ksana Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Must not have

Development disability precluding comprehension of study procedures

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weekly

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve the effectiveness of a suicide safety planning app called ViraBrite by integrating automated algorithms to increase user engagement with coping skills and safety planning materials during times of high risk.

Who is the study for?

This trial is for adolescents struggling with mental health issues, including thoughts of suicide or anhedonia (inability to feel pleasure). Participants should be comfortable using a smartphone app designed to help with suicide safety planning. There are specific inclusion and exclusion criteria not detailed here.

What is being tested?

The study tests ViraBrite nudges within the BRITE app, which aims to improve engagement in coping skills and provide timely support during high-risk periods. This 4-week trial uses just-in-time adaptive interventions via smartphones to potentially prevent suicides among youth.

What are the potential side effects?

Since this intervention involves digital tools rather than medication, traditional side effects are not applicable. However, there may be emotional or psychological impacts from engaging with the content that will be monitored throughout the study.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I understand the study procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Engagement with ViraBrite

Proximal engagement with ViraBrite

Secondary study objectives

Columbia Suicide Severity Rating Scale (C-SSRS)

Mood and Feelings Questionnaire (MFQ)

Reasons for Living

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ViraBriteExperimental Treatment1 Intervention

Each day, participants will receive nudges according to a micro-randomized pattern that encourage them to access the ViraBrite app and utilize coping and suicide safety planning skills. One decision point will occur per day. At each decision point, participants will have a seventy-five percent chance of receiving a nudge. Given that they are randomized to receive a nudge, participants have a 33.3% chance of receiving a notification at one of three time points: morning, midday or evening.

0 / 1Eligibility criteria met